ASVRX
Price
$10.61
Change
+$0.09 (+0.86%)
Updated
Aug 21 closing price
Net Assets
2.96B
RYTFX
Price
$8.22
Change
+$0.07 (+0.86%)
Updated
Aug 21 closing price
Net Assets
941.46M
Interact to see
Advertisement

ASVRX vs RYTFX

ASVRX vs RYTFX Comparison Chart in %
View a ticker or compare two or three
VS
ASVRX vs. RYTFX commentary
Aug 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ASVRX is a Hold and RYTFX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
ASVRX has more cash in the bank: 2.96B vs. RYTFX (941M). RYTFX pays higher dividends than ASVRX: RYTFX (0.65) vs ASVRX (0.42). ASVRX was incepted earlier than RYTFX: ASVRX (16 years) vs RYTFX (25 years). RYTFX (1.60) and ASVRX (1.58) have similar cost to investors . RYTFX is a more actively managed with annual turnover of: 59.00 vs. ASVRX (42.00). RYTFX has a lower initial minimum investment than ASVRX: RYTFX (2000) vs ASVRX (2500). ASVRX annual gain was more profitable for investors over the last year : 7.69 vs. RYTFX (4.21). ASVRX return over 5 years is better than : 1.09 vs. RYTFX (-21.89).
ASVRXRYTFXASVRX / RYTFX
Total Expense Ratio1.581.49106%
Annual Report Gross Expense Ratio1.581.6099%
Fund Existence16 years25 years-
Gain YTD23.66014.313165%
Front LoadN/AN/A-
Min. Initial Investment25002000125%
Min. Initial Investment IRAN/AN/A-
Net Assets2.96B941M315%
Annual Yield % from dividends0.420.6564%
Returns for 1 year7.694.21183%
Returns for 3 years17.8316.25110%
Returns for 5 years1.09-21.89-5%
Returns for 10 years31.47-33.59-94%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HCPIX133.462.62
+2.00%
ProFunds UltraSector Health Care Inv
IVNCX22.680.17
+0.76%
Nomura Global Growth Fund Class C
PVMIX18.270.12
+0.66%
Principal MidCap Value I Inst
HSMRX15.600.09
+0.58%
Hartford Small Cap Value R3
JMVSX35.980.19
+0.53%
JPMorgan Mid Cap Value I